U.S. Sen. Alex Padilla visited UC Irvine on September 8 to learn about the university's research efforts in improving health, driving innovation, and advancing treatments for Alzheimer’s disease and other forms of dementia.
During his visit, Senator Padilla met with campus leaders, who provided presentations on UC Irvine’s comprehensive research portfolio, UCI Health, Beall Applied Innovation, and UCI MIND. Following these discussions, Padilla toured a UCI MIND laboratory. UCI MIND functions as UC Irvine’s interdisciplinary research center, specifically dedicated to understanding, diagnosing, treating, and ultimately preventing Alzheimer’s disease and various forms of dementia.
Senator Padilla noted that federally funded research at universities contributes to shaping the future of health and technology. He highlighted the work at the UCI MIND laboratory, where researchers are advancing medical breakthroughs for millions of Americans, and expressed interest in how Congress can support research that makes a meaningful difference in patients' lives.
Aileen Anderson, UC Irvine's vice chancellor for research, emphasized the importance of sustained federal investment in university research. Anderson pointed out that uncertainty in the funding pipeline presents challenges in maintaining laboratories, research programs, and opportunities for students. She also described the essential role academic research centers play in transitioning discoveries from basic research through clinical trials to benefit patients.
Dr. Michael Stamos, interim vice chancellor for health affairs and dean of the School of Medicine, detailed UCI Health’s expanding network of hospitals and clinics. He also discussed UC Irvine’s four health sciences schools—medicine, nursing, pharmacy, and public health—and how robust translational and clinical research in these areas leads to new discoveries, products, treatments, and cures, while also preparing the future healthcare workforce.
Errol Arkilic, UC Irvine’s chief innovation officer, outlined the university’s infrastructure designed to transform research discoveries into marketable products and services. Arkilic described efforts to facilitate the movement of innovations from the laboratory to the marketplace, covering fields such as medical devices, artificial intelligence, aerospace, and national security. He cited specific examples of UC Irvine technologies progressing toward commercialization.
Joshua Grill, director of UCI MIND, presented recent advances in Alzheimer’s research. His report included developments in PET imaging, blood-based testing, and new treatments. Grill also discussed ongoing initiatives to increase Latino participation in clinical trials.
Overall, the visit provided UC Irvine with an opportunity to demonstrate how research conducted at public universities can enhance the health and quality of life for Americans. Vice Chancellor Anderson expressed gratitude for Senator Padilla’s interest in hearing directly from researchers about their work and recognizing the vital role public research universities fulfill in improving public health and well-being.
